KRTX - Karuna Therapeutics Inc
Close
329.83
0.090 0.027%
Share volume: 0
Last Updated: Fri 15 Mar 2024 09:00:01 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$329.74
0.09
0.03%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-05 | 2022-08-08 | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-03 | 2023-11-02 | |
| Assets | ||||||||
| Total Assets | 474.474 M | 433.556 M | 1.228 B | 1.163 B | 1.516 B | 1.472 B | 1.385 B | |
| Current Assets | 464.639 M | 424.181 M | 1.220 B | 1.155 B | 1.508 B | 1.452 B | 1.365 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 21.452 M | 12.017 M | 27.563 M | 30.668 M | 33.044 M | 15.437 M | 23.783 M | |
| Short Term Investments | 21.452 M | 12.017 M | 27.563 M | 30.668 M | 33.044 M | 15.437 M | 23.783 M | |
| Total Receivables | 0.000 | 4.750 M | 81.000 K | 57.000 K | 261.000 K | 0.000 | 0.000 | |
| Current Cash | 443.187 M | 407.414 M | 1.192 B | 1.124 B | 1.474 B | 1.437 B | 1.342 B | |
| Total Non-current Assets | 9.835 M | 9.375 M | 8.734 M | 8.565 M | 8.409 M | 20.156 M | 19.700 M | |
| Property Plant Equipment | 3.050 M | 3.079 M | 2.919 M | 3.201 M | 3.721 M | 4.182 M | 4.715 M | |
| Other Assets | 6.524 M | 6.035 M | 5.554 M | 5.103 M | 4.688 M | 15.974 M | 14.985 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 474.474 M | 433.556 M | 1.228 B | 1.163 B | 1.516 B | 1.472 B | 1.385 B | |
| Total liabilities | 20.786 M | 28.147 M | 44.457 M | 37.096 M | 28.033 M | 52.540 M | 62.781 M | |
| Total current liabilities | 15.923 M | 23.868 M | 40.745 M | 33.946 M | 25.237 M | 38.603 M | 48.968 M | |
| Accounts Payable | 1.478 M | 3.920 M | 15.716 M | 2.379 M | 476.000 K | 1.102 M | 2.939 M | |
| Other liabilities | 104.000 K | 104.000 K | 104.000 K | 104.000 K | 104.000 K | 104.000 K | 0.000 | |
| Current long term debt | 2.219 M | 2.262 M | 2.278 M | 2.282 M | 2.067 M | 1.977 M | 1.796 M | |
| Long term debt | 4.759 M | 4.175 M | 3.608 M | 3.046 M | 2.692 M | 13.833 M | 13.813 M | |
| Other liabilities | 104.000 K | 104.000 K | 104.000 K | 104.000 K | 104.000 K | 104.000 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 453.688 M | 405.409 M | 1.184 B | 1.126 B | 1.488 B | 1.420 B | 1.322 B | |
| Common stock | 29.806 M | 29.896 M | 32.349 M | 34.465 M | 34.801 M | 37.525 M | 37.689 M | |
| Retained earnings | -346.089 M | -411.032 M | -487.995 M | -564.207 M | -661.781 M | -764.944 M | -884.063 M |